In this pilot study, we address the nature of the re-population of the T-cell compartment in HIV-1 1 (Human Immunodeficiency Virus 1), vertically infected children placed on successful regimens of HAART (highly active anti-retroviral therapy) incorporating 2 NRTI and a protease inhibitor. The clonality of the T-cell compartment and the abundance of RTEs (Recent Thymic Emigrants) were determined 2 weeks before and 20 weeks after initiation of HAART in a subgroup of children taking part in the PENTA (Paediatric European Network for the Treatment of AIDS) 5 trial. Analysis of the clonality of the circulating T-cell compartment was assessed using CDR3 spectratyping and analysed using the Kolmogorov±Smirnov two sample test. This revealed that a high degree of T-cell clonal restriction still exists 5 months into therapy, despite the appearance of previously undetectable T-cell clones within the periphery. We detected no increase in RTE abundance in this 5 month period, as determined by PCR detection of TRECs (T-Cell Receptor Excision Circles). We conclude that the observed re-population of T cells within the periphery of treated children is heavily reliant upon the maintenance/expansion of preexisting cells during the 5 month period immediately following the initiation of therapy.
INTRODUCTION
The immune system of children is less well understood than that of adults [1, 2] , and it is not clear how they respond to HIV infection and what therapeutic strategies should be used. It is important to evaluate how the paediatric T-lymphocyte compartment is impaired by HIV infection and how this responds to HAART.
Prior to the initiation of therapy, HIV-infected children show a substantial up-regulation of the activation induced apoptotic marker CD95 (APO-1) [3, 4] on their T cells compared with uninfected children. It is conceivable that this contributes significantly to the pathology of the infection [5] , decreasing the average life span of the child's T cells and de-populating the peripheral pool [6, 7] . Such a de-population has been shown to result in a clonally-restricted and dysfunctional T-cell pool in adults, which is not immediately repairable through the application of anti-retroviral therapy [8] .
It has already been shown that following the introduction of HAART (Highly Active Anti-Retroviral Therapy) in adults, the initial re-population of the peripheral T-cell compartment is highly dependant upon a composite of T-cell re-distribution from other sites and proliferation of pre-existing cells [9±12] . In children, the thymus has a far higher output of T cells than in the adult, with a decrease only setting in dramatically after puberty [13] . It is therefore feasible that the high level of thymic output evident in children could rapidly`re-establish' a diverse T-cell compartment in such patients responding successfully to HAART. To determine whether this was the case, the clonality of the T-cell compartment before and after therapy was assessed in four children, using CDR3 spectratyping [14±17]. This technique is a PCR-based method for visualizing the composition of the T-cell receptor (TCR) repertoire. Primers specific for elements within the T-cell receptor produce measurable products, corresponding to the length of the Vb CDR3 (Complementarity Determining Region 3) chain. By analysing the amount of product generated for each possible CDR3 chain within each TCRVb family, the entire T-cell pool can be finely examined.
In this study, we analyse the apparent reconstitution of the Tlymphocyte population in children taking part in the PENTA (Paediatric European Network Treatment AIDS) 5 trial [18] , placed on successful regimens of HAART, incorporating 2 NRTI and a protease inhibitor. participating in the PENTA 5 trial were included. Treatment consisted of 2 NRTI (2 of Abacavir, ZDV or 3TC) plus Nelfinavir. All responded well to therapy, having a significant reduction in viral load (VL) (Roche Amplicor/Roche Ultrasensitive) and an increase in the CD4 1 T-lymphocyte number ( Table 1) .
Samples
Frozen samples of PBMCs (Peripheral Blood Mononuclear Cells) were obtained. The samples from each of the children consisted of paired samples taken 2 weeks before and 20 weeks after the initiation of HAART.
Sample preparation
PBMCs were thawed and lysed by resuspension in Tri-Reagent (Sigma). DNA and RNA were extracted as per the manufacturer's instructions. The RNA was used to create cDNA, primed with 16mer oligo dT, as per the manufacturer's recommendations (all reagents Perkin-Elmer Applied Biosystems, Warrington, UK).
CDR3 spectratyping
The PCR to amplify each of the functional Vb CDR3 regions was set up as follows. Reactions (25 ml) containing 2 ml 25 mm magnesium chloride, 2´5 ml Â10 PCR buffer, 0´5 ml mixed 10 mm dNTP, 0´2 ml cDNA, 0´6 U Taq polymerase, and previously published primers specific for the constant region (Cb) and the variable region (Vb) of interest [14±17], were run under the conditions of 958C for 30 s, then 50 cycles of 958C for 25 s, 608C
for 45 s and 728C for 45 s, before a final elongation of 728C for 5 min. The PCR products generated from the above reaction were subjected to flurophore-labelled, single primer elongations. The primers were specific for the constant region (Cb) of the TCR b chain or to individual Joining region (Jb) segments. These were performed under identical cycling conditions to the amplification PCR for between five and 10 cycles. The labelled products were loaded onto an ABI 310 Automate (Perkin-Elmer Applied Biosystems, UK), which measures the intensity of fluorescence (the amount of PCR product), and, by reference to the detection time of the internal size standards, the length of the PCR products was determined. The profiles or`CDR3 spectratypes' generated from this may then be compared visually with one another to detect expansions, or assessed statistically to determine alterations in the composition or levels of perturbation, as described below. 
Statistical analysis

TREC analysis
Using the previously published primer sequences and PCR conditions for the detection of Signal Joint TRECs [20] , excision circle abundance within the T-cell compartment was assessed. P 32 -labelled dATP was incorporated into the PCR products by inclusion of Redivue aP 32 -dATP (Pharmacia, Little Chalfont, UK) as 5% of the total nucleotides. Following agarose gel electrophoresis and ethidium bromide staining, the bands were excised from the gel and incorporation of P 32 was measured using a Wallac 1205 betaplate-counter (Perkin-Elmer Life Sciences, Warrington, UK). The P 32 TREC signal was standardized against an internal b-actin P 32 PCR signal. Triplicates of positive control samples, incorporating DNA extracted from purified CD4 1 cells, were run simultaneously at 1:1, 1:2 and 1:10 dilutions to assure assay performance and sensitivity (data not shown).
RESULTS
T-cell clonality
To assess the clonality of the T-cell compartment, the CDR3specific PCR described above was employed, generating CDR3 spectratypes for the functional Vb families (Fig. 1a ). Kolmogorov± Smirnov statistics were then used to determine the difference (Dmax, ranging between 0 and 1) between the individual Vb families in each child, before and after therapy ( Table 2) , to reveal any alterations in the composition of the circulating T-cell compartment. This revealed a noticeable difference in the clonal composition of the T-cell compartment before and after treatment, with the average Dmax for P5/1 being 0´449, P5/2 0´451, P5/3 0´289 and P5/4 0´678. The high Dmax values indicate that a large difference exists between the 2 weeks prior to HAART and 20 weeks post HAART initiation time points analysed.
Conserved clonal T-cell expansions
Despite the prompt and sustained reduction in viremia and the rise in the number of peripheral CD4 1 T cells during 5 months of HAART (Table 1) , over-represented CDR3 PCR products of identical length were found before, and 5 months into, therapy in a number of TCRVb CDR3 clusters in all four children (Fig. 2) . By probing the products of the pre-labelled PCR reactions with flurophore-bound primers specific for each of the Jb segments, we were able to dissect further the TCRVb families into their constituent 13 Jb elements, so that their clonality could be more closely evaluated. This technique was used to examine the TCRVb clusters where an expansion of the same dominant CDR3 lengths was present in both the 2 weeks prior to HAART and 20 week post initiation of HAART time points. This revealed that these conserved TCRVb expansions are maintained within the same Jb families between the two time points (22 weeks time span), providing strong evidence for their clonal nature (Fig. 3) .
TREC level in paediatric group
During the rearrangement of TCR genes to create the TCR, excisional, stable circles of DNA are generated. These fail to duplicate during mitosis and are subsequently diluted out in cellular populations during proliferation [20] . As such, PCRs targeting regions of these circles may be used to assess the replicative history of a cellular population, or rather, the contribution of recent thymic emigrants to the T-cell compartment. DNA extracted from the same cells as the RNA was used in PCR reactions to assess relative TREC levels in the paediatric samples.
By standardizing the sjTREC products against an internal marker, no increase in the relative abundance post therapy (Table 1 .) in any of the children was observed. Therefore, no substantial increase in the number of recent thymic emigrants in the peripheral circulation due to HAART was recorded.
DISCUSSION
The TCRVb repertoire studies undertaken here display alterations in the clonal composition of the repertoire in four children after 5 months of successful HAART (Fig. 1, Table 2 ). The fact that initially undetectable CDR3 spectratype products of certain TCRVb families are found following therapy is encouraging (Figs 1 and 2 ), suggesting the re-establishment of truly naive cells within the periphery [13, 20] , a decrease in the size of the expansions within the CD8 1 compartment [21] allowing the detection of less frequent CDR3 lengths, or the redistribution of sequestered cells from other sites following the alleviation of viral burden [9] . Should redistribution of sequestered cells be a major cause of this change in peripheral T-cell pool composition, it would occur rapidly following the suppression of viremia [11, 22] , though the result of this would persist, allowing detection at the 20 week time point. Any of the aforementioned scenarios could increase the apparent diversity within the circulating T-cell compartment, although the production of new, naive cells would arguably be the most beneficial to the subject, representing true immune reconstitution. These results must be interpreted with caution because of small numbers. However, there is strong evidence that initially over-represented TCRVb CDR3 expansions are maintained over a period of 5 months on HAART (Figs 1, 2 and 3) in each of the children. Such data suggest that specific cells are, at the very least, maintaining their place within the periphery, if not actively proliferating to re-populate the circulating cellular compartment. There are several possible explanations of the persistence of these dominant CDR3 lengths. They may represent cells responding to on-going antigenic stimuli other than the HIV-derived antigens; influx of new cells could be insufficient to displace these overrepresented cells; and/or the level of residual HIV antigens [23] may be sufficient to maintain a clonal HIV-specific response. The phenomenon of mature CD4 1 T cells proliferating after successful HAART intervention in HIV-infected adults has already been observed [12] , and peripheral expansion of T cells has been shown in animal models [24±26] . Recently, the observation that the size of the CD8 1 CD28 2 T-cell population continues to be significantly elevated in HIV-infected children up 12 months after the initiation of HAART [27] (compared with uninfected children) would suggest that these cells could be clonally restricted.
Recent thymic emigrants were seen in all of the children both before and after therapy, despite low CD4 counts at baseline, demonstrating the relatively high thymic function in children. In agreement with Zhang et al. [13] , we failed to detect an increase in TREC relative abundance (Table 1) after 5 months of therapy; this does not exclude a contribution to the periphery by RTEs but suggests rather that their relative level does not increase. Whether this is due to factors such as activation and proliferation, rapid turn-over, or the over-abundance of the detected clonal expansions is unclear. Others, such as Douek [20] , have reported an increase in RTE levels post therapy.
Bohler et al. [28] , monitoring the efficacy of HAART in children, noted a decrease in expression of the apoptotic marker CD95 following therapeutic intervention. This may suggest a down-regulation of the activation-induced naive to memory phenotype``switch', and a subsequent decrease in activationinduced apoptosis, which would certainly agree with our observations.
Our findings imply that in successful paediatric therapy, with a decrease in viral load and an increase in CD4 1 T-cell numbers, the reconstitution of the peripheral T-cell compartment is a composite of redistribution of cells from other sites and the proliferation of pre-existing T cells, possibly mirroring data which have been reported in adults [9] , despite the differences in thymic function in adults and children.
In children, those cells which are present at the initiation of therapy would appear to play a significant role in the subsequent composition of the T-cell repertoire. Though this may be diluted out over a greater period of time, after 5 months of HAART intervention, the continued clonal restriction is very apparent and could limit the breadth of antigens that the`pool' would recognize.
